SPONSOR

University of California, Davis

Total Trials

Recruiting

Phases

Phase 3, Phase 1, Phase 4, Phase 2, EARLY_Phase 1

Conditions studied: Zinc Deficiency Inflammation Metabolic Diseases Vascular Diseases Myofascial Pain Syndrome (MPS)Chronic Low-back Pain (cLBP)Overactive Bladder Syndrome Neuropathic Bladder Congenital Diaphragmatic Hernia Impulsivity

University of California, Davis is a clinical research sponsor with 19 registered studies on ClinicalTrials.gov, of which 19 are actively recruiting participants. Research covers conditions including Zinc Deficiency, Inflammation, Metabolic Diseases, Vascular Diseases.

The trial portfolio spans Phase 3, Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of California, Davis

How many clinical trials has University of California, Davis sponsored?

ClinicalMetric currently tracks 19 clinical trials sponsored by University of California, Davis, of which 19 are actively recruiting participants. These trials cover conditions including Zinc Deficiency, Inflammation, Metabolic Diseases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of California, Davis research focus on?

University of California, Davis clinical trials span Zinc Deficiency, Inflammation, Metabolic Diseases, Vascular Diseases, Myofascial Pain Syndrome (MPS), and additional conditions. The research pipeline includes Phase 3, Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of California, Davis clinical trial?

To participate in a University of California, Davis trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of California, Davis trials with current recruitment status updated daily.

University of California, Davis

Frequently Asked Questions — University of California, Davis

Clinical Trials by University of California, Davis

Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc

Imaging Metabolic and Perfusion Changes in Acupuncture Therapy for Myofascial Pain Syndrome

Oxybutynin for Post-surgical Bladder Pain and Urgency

Fetal Endoscopic Tracheal Occlusion for CDH (CDH)

Shaping Tolerance for Delayed Rewards

Zinc and Iron Absorption From Common Beans in Young Adult Women

Cognitive and Electrophysiological Assessment of Non-Invasive Temporally-Interfering Electric Fields Stimulation (TIEFS)

Genetic Basis of Melanocytic Nevi

Alternation in the Human Microbiome With Commonly Used Topical Medications

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet

Engaging Mental Effort: Process- and Person-Based Reward Experiences, Effort Reinforcement Intervention, and Cascading Effects on Challenging Tasks

Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)

Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Fidgeting and Attentional and Emotional Regulation in ADHD

Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)